Remote Visits White Paper Pediatric Clinical Trialszeisgroup2018-06-20T18:06:31+00:00
WHITE PAPER: USING A REMOTE-VISIT SERVICES (RVS) MODEL TO ADDRESS CHALLENGES OF PEDIATRIC CLINICAL TRIALS
Legislative changes in the United States and Europe have increased the responsibility of drug developers to study the agents they market for children, ensuring clinicians have adequate efficacy, safety, and dosing information to effectively prescribe appropriate drugs to children. Additionally, pediatric trials often encounter unique barriers to successful trial completion, such as patients discontinuing early from the trial; parental perceptions, motivations, and attitudes of the benefit and burden of trial participation; and the inherent unique characteristics of the pediatric patient population. How can drug developers overcome these potential barriers?
Download this white paper to learn how a remote-visit services model can address these challenges. The white paper examines:
The pediatric clinical trial landscape
Current challenges conducting pediatric clinical trials
Firma Clinical’s 7 best practices to meet these challenges with a Remote-Visit Services (RVS) or in-home care model that enhances and improves support for pediatric patients and their guardians/caregivers, and better positions trials for optimal participation and adherence
Fill out the short form to download the White Paper!
By filling out this form you agree to receive Firma promotional messages and content.